Literature DB >> 26521275

Gaining insights into pulmonary hypertension in respiratory diseases.

Joan Albert Barberà1, Isabel Blanco2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26521275     DOI: 10.1183/13993003.01288-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.

Authors:  Lauren Rose; Kurt W Prins; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Jeffrey R Misialek; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2018-09-14       Impact factor: 10.247

2.  Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.

Authors:  Kurt W Prins; Lauren Rose; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Felipe Kazmirczak; Jeffrey R Misialek; Thenappan Thenappan
Journal:  Am J Respir Crit Care Med       Date:  2018-06-01       Impact factor: 21.405

3.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

4.  Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study.

Authors:  Nadine Al-Naamani; Hao-Min Pan; Michaela R Anderson; Drew A Torigian; Yubing Tong; Michelle Oyster; Mary K Porteous; Scott Palmer; Selim M Arcasoy; Joshua M Diamond; Jayaram K Udupa; Jason D Christie; David J Lederer; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2020-11

5.  Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis.

Authors:  Kurt W Prins; Sue Duval; Jeremy Markowitz; Marc Pritzker; Thenappan Thenappan
Journal:  Pulm Circ       Date:  2017-03-24       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.